Tubocurarine | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | |
Tubocurarine | hsa00220 | Arginine biosynthesis | 4.88E-02 | 1 | P49448 | GLUD2 | More | |
Tubocurarine | hsa00250 | Alanine, aspartate and glutamate metabolism | 4.88E-02 | 1 | P49448 | GLUD2 | More | |
Tubocurarine | hsa00471 | D-Glutamine and D-glutamate metabolism | 1.65E-02 | 1 | P49448 | GLUD2 | More | |
Tubocurarine | hsa00500 | Starch and sucrose metabolism | 1.67E-02 | 2 | O43451, P06737 | MGAM, PYGL | More | |
Tubocurarine | hsa00730 | Thiamine metabolism | 5.29E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | |
Tubocurarine | hsa00830 | Retinol metabolism | 3.49E-02 | 1 | P00325 | ADH1B | More | |
Tubocurarine | hsa00910 | Nitrogen metabolism | 4.88E-02 | 1 | P49448 | GLUD2 | More | |
Tubocurarine | hsa00983 | Drug metabolism - other enzymes | 2.44E-02 | 2 | P32320, P05164 | CDA, MPO | More | |
Tubocurarine | hsa01522 | Endocrine resistance | 4.96E-02 | 3 | Q16539, P04637, P10415 | MAPK14, TP53, BCL2 | More | |
Tubocurarine | hsa03008 | Ribosome biogenesis in eukaryotes | 1.56E-02 | 3 | Q9NYH9, P78345, O15381 | UTP6, RPP38, NVL | More | |
Tubocurarine | hsa03060 | Protein export | 3.28E-02 | 1 | Q15070 | OXA1L | More | |
Tubocurarine | hsa04014 | Ras signaling pathway | 4.65E-02 | 3 | Q15311, P0DP23, P17612 | RALBP1, CALM1, PRKACA | More | |
Tubocurarine | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 1.12E-03 | 10 | P51684, P32248, P09341, P19875, P25024, P02775, P25025, P47992, Q9UBD3, P14784 | CCR6, CCR7, CXCL1, CXCL2, CXCR1, PPBP, CXCR2, XCL1, XCL2, IL2RB | More | |
Tubocurarine | hsa04062 | Chemokine signaling pathway | 1.83E-02 | 8 | P25024, P25025, P09341, P19875, P42338, P19174, P63218, P50151 | CXCR1, CXCR2, CXCL1, CXCL2, PIK3CB, PLCG1, GNG5, GNG10 | More | |
Tubocurarine | hsa04064 | NF-kappa B signaling pathway | 2.15E-02 | 7 | P14778, P19174, Q04759, P06239, P09341, P19875, Q06643 | IL1R1, PLCG1, PRKCQ, LCK, CXCL1, CXCL2, LTB | More | |
Tubocurarine | hsa04071 | Sphingolipid signaling pathway | 1.94E-02 | 3 | Q9H228, P01375, Q9UQC2 | EDG8, TNF, GAB2 | More | |
Tubocurarine | hsa04072 | Phospholipase D signaling pathway | 4.48E-02 | 5 | P42338, P43657, P25024, P25025, P19174 | PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1 | More | |
Tubocurarine | hsa04114 | Oocyte meiosis | 2.15E-02 | 3 | P0DP23, P17612, Q13362 | CALM1, PRKACA, PPP2R5C | More | |
Tubocurarine | hsa04144 | Endocytosis | 4.07E-03 | 5 | Q9H444, O75351, P42566, Q15438, Q14161 | CHMP4B, VPS4B, EPS15, PSCD1, GIT2 | More | |
Tubocurarine | hsa04152 | AMPK signaling pathway | 2.34E-02 | 2 | Q96EB6, P36956 | SIRT1, SREBF1 | More | |
Tubocurarine | hsa04210 | Apoptosis | 1.73E-03 | 10 | P04637, P10415, O76075, P01375, Q9NR28, P24522, Q16548, Q13077, P43234, Q14643 | TP53, BCL2, DFFB, TNF, DIABLO, GADD45A, BCL2A1, TRAF1, CTSO, ITPR1 | More | |
Tubocurarine | hsa04213 | Longevity regulating pathway - multiple species | 3.85E-02 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | |
Tubocurarine | hsa04217 | Necroptosis | 4.56E-03 | 4 | P23458, Q9NQC7, Q9H444, O75351 | JAK1, CYLD, CHMP4B, VPS4B | More | |
Tubocurarine | hsa04261 | Adrenergic signaling in cardiomyocytes | 2.50E-02 | 3 | P17612, Q13362, P0DP23 | PRKACA, PPP2R5C, CALM1 | More | |
Tubocurarine | hsa04340 | Hedgehog signaling pathway | 3.32E-02 | 2 | P49841, P22694 | GSK3B, PRKACB | More | |
Tubocurarine | hsa04640 | Hematopoietic cell lineage | 1.37E-02 | 7 | P14778, P27930, P11215, P25063, P07766, P01732, P09564 | IL1R1, IL1R2, ITGAM, CD24, CD3E, CD8A, CD7 | More | |
Tubocurarine | hsa04650 | Natural killer cell mediated cytotoxicity | 2.48E-03 | 8 | P19174, P06239, O60880, P20963, P42338, Q13241, P26718, O14931 | PLCG1, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3 | More | |
Tubocurarine | hsa04657 | IL-17 signaling pathway | 3.31E-02 | 3 | P49841, P14780, P01375 | GSK3B, MMP9, TNF | More | |
Tubocurarine | hsa04658 | Th1 and Th2 cell differentiation | 2.55E-05 | 12 | Q04759, P07766, P20963, P09693, Q16539, P19174, P06239, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, LCK, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | |
Tubocurarine | hsa04659 | Th17 cell differentiation | 1.25E-03 | 8 | Q04759, P19174, P06239, P14784, P14778, Q9UL17, P07766, P20963 | PRKCQ, PLCG1, LCK, IL2RB, IL1R1, TBX21, CD3E, CD247 | More | |
Tubocurarine | hsa04660 | T cell receptor signaling pathway | 3.37E-03 | 8 | Q04759, P42338, P19174, P07766, P20963, P01732, Q13191, P06239 | PRKCQ, PIK3CB, PLCG1, CD3E, CD247, CD8A, CBLB, LCK | More | |
Tubocurarine | hsa04713 | Circadian entrainment | 4.42E-02 | 2 | P0DP23, P17612 | CALM1, PRKACA | More | |
Tubocurarine | hsa04720 | Long-term potentiation | 4.42E-02 | 2 | P0DP23, P17612 | CALM1, PRKACA | More | |
Tubocurarine | hsa04722 | Neurotrophin signaling pathway | 2.34E-02 | 4 | Q16566, P04637, Q16539, P10415 | CAMK4, TP53, MAPK14, BCL2 | More | |
Tubocurarine | hsa04725 | Cholinergic synapse | 3.92E-02 | 3 | Q14643, Q16566, P10415 | ITPR1, CAMK4, BCL2 | More | |
Tubocurarine | hsa04728 | Dopaminergic synapse | 1.55E-02 | 3 | P17612, Q13362, P0DP23 | PRKACA, PPP2R5C, CALM1 | More | |
Tubocurarine | hsa04740 | Olfactory transduction | 6.71E-03 | 2 | P0DP23, P17612 | CALM1, PRKACA | More | |
Tubocurarine | hsa04750 | Inflammatory mediator regulation of TRP channels | 7.24E-03 | 5 | P14778, P19174, P42338, P24723, Q04759 | IL1R1, PLCG1, PIK3CB, PRKCH, PRKCQ | More | |
Tubocurarine | hsa04910 | Insulin signaling pathway | 1.91E-03 | 5 | P0DP23, P17612, P22694, P06737, P49841 | CALM1, PRKACA, PRKACB, PYGL, GSK3B | More | |
Tubocurarine | hsa04916 | Melanogenesis | 2.87E-02 | 2 | P17612, P0DP23 | PRKACA, CALM1 | More | |
Tubocurarine | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | |
Tubocurarine | hsa04921 | Oxytocin signaling pathway | 1.84E-02 | 3 | P0DP23, P17612, Q96RR4 | CALM1, PRKACA, CAMKK2 | More | |
Tubocurarine | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | |
Tubocurarine | hsa04924 | Renin secretion | 1.09E-02 | 2 | P17612, P0DP23 | PRKACA, CALM1 | More | |
Tubocurarine | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | |
Tubocurarine | hsa04964 | Proximal tubule bicarbonate reclamation | 4.88E-02 | 1 | P49448 | GLUD2 | More | |
Tubocurarine | hsa04970 | Salivary secretion | 2.20E-02 | 2 | P17612, P0DP23 | PRKACA, CALM1 | More | |
Tubocurarine | hsa04971 | Gastric acid secretion | 2.87E-02 | 2 | P17612, P0DP23 | PRKACA, CALM1 | More | |
Tubocurarine | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | |
Tubocurarine | hsa04976 | Bile secretion | 1.19E-03 | 4 | P17612, P22694, P08183, Q14032 | PRKACA, PRKACB, ABCB1, BAAT | More | |
Tubocurarine | hsa05031 | Amphetamine addiction | 2.87E-02 | 2 | P0DP23, P17612 | CALM1, PRKACA | More | |
Tubocurarine | hsa05034 | Alcoholism | 1.29E-02 | 3 | P17612, P0DP23, Q96RR4 | PRKACA, CALM1, CAMKK2 | More | |
Tubocurarine | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.78E-03 | 5 | P09341, P19875, P19174, P25024, P25025 | CXCL1, CXCL2, PLCG1, CXCR1, CXCR2 | More | |
Tubocurarine | hsa05134 | Legionellosis | 1.29E-02 | 4 | P11215, P11142, P09341, P19875 | ITGAM, HSPA8, CXCL1, CXCL2 | More | |
Tubocurarine | hsa05146 | Amoebiasis | 2.21E-04 | 8 | P09341, P19875, P14778, P27930, P42338, P11215, P05089, P12814 | CXCL1, CXCL2, IL1R1, IL1R2, PIK3CB, ITGAM, ARG1, ACTN1 | More | |
Tubocurarine | hsa05169 | Epstein-Barr virus infection | 3.45E-02 | 6 | P13765, P04637, P10415, Q16539, P24522, P09693 | HLA-DOB, TP53, BCL2, MAPK14, GADD45A, CD3G | More | |
Tubocurarine | hsa05202 | Transcriptional misregulation in cancer | 2.62E-02 | 7 | Q15532, P14923, Q13077, O15550, P04637, P05164, P24522 | SS18, JUP, TRAF1, UTX, TP53, MPO, GADD45A | More | |
Tubocurarine | hsa05210 | Colorectal cancer | 2.89E-02 | 4 | P10415, P04637, Q9UJU2, P24522 | BCL2, TP53, LEF1, GADD45A | More | |
Tubocurarine | hsa05212 | Pancreatic cancer | 2.87E-02 | 2 | Q15311, P23458 | RALBP1, JAK1 | More | |
Tubocurarine | hsa05213 | Endometrial cancer | 2.21E-02 | 3 | Q9UJU2, P04637, P24522 | LEF1, TP53, GADD45A | More | |
Tubocurarine | hsa05214 | Glioma | 2.21E-02 | 3 | Q16566, P04637, P24522 | CAMK4, TP53, GADD45A | More | |
Tubocurarine | hsa05216 | Thyroid cancer | 6.17E-03 | 3 | Q9UJU2, P04637, P24522 | LEF1, TP53, GADD45A | More | |
Tubocurarine | hsa05217 | Basal cell carcinoma | 1.56E-02 | 3 | Q9UJU2, P04637, P24522 | LEF1, TP53, GADD45A | More | |
Tubocurarine | hsa05221 | Acute myeloid leukemia | 3.00E-02 | 3 | P14923, Q9UJU2, P05164 | JUP, LEF1, MPO | More | |
Tubocurarine | hsa05222 | Small cell lung cancer | 2.34E-02 | 4 | P10415, Q13077, P04637, P24522 | BCL2, TRAF1, TP53, GADD45A | More | |
Tubocurarine | hsa05224 | Breast cancer | 4.96E-02 | 3 | Q9UJU2, P04637, P24522 | LEF1, TP53, GADD45A | More | |
Tubocurarine | hsa05226 | Gastric cancer | 1.12E-02 | 5 | Q9UJU2, P04637, P24522, P14923, P10415 | LEF1, TP53, GADD45A, JUP, BCL2 | More | |
Tubocurarine | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 8.27E-03 | 6 | P42338, P19174, P07766, P20963, P06239, Q04759 | PIK3CB, PLCG1, CD3E, CD247, LCK, PRKCQ | More | |